Inovio Stock Volatility

INO
 Stock
  

USD 1.73  0.11  5.98%   

Inovio Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0571, which attests that the entity had -0.0571% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Inovio Pharmaceuticals exposes twenty-seven different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Inovio Pharmaceuticals market risk adjusted performance of (0.015942), and Risk Adjusted Performance of (0.006177) to validate the risk estimate we provide.
  
Inovio Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Inovio daily returns, and it is calculated using variance and standard deviation. We also use Inovio's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Inovio Pharmaceuticals volatility.

60 Days Market Risk

Unstable

Chance of Distress

60 Days Economic Sensitivity

Hyperactively responds to market trends
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Inovio Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Inovio Pharmaceuticals at lower prices. For example, an investor can purchase Inovio stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Inovio Pharmaceuticals' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Inovio Pharmaceuticals Market Sensitivity And Downside Risk

Inovio Pharmaceuticals' beta coefficient measures the volatility of Inovio stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Inovio stock's returns against your selected market. In other words, Inovio Pharmaceuticals's beta of 2.13 provides an investor with an approximation of how much risk Inovio Pharmaceuticals stock can potentially add to one of your existing portfolios.
Inovio Pharmaceuticals exhibits very low volatility with skewness of 0.49 and kurtosis of 0.91. However, we advise investors to further study Inovio Pharmaceuticals technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Inovio Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Inovio Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
3 Months Beta |Analyze Inovio Pharmaceuticals Demand Trend
Check current 90 days Inovio Pharmaceuticals correlation with market (NYSE Composite)

Inovio Beta

    
  2.13  
Inovio standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  5.15  
It is essential to understand the difference between upside risk (as represented by Inovio Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Inovio Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in inovio stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Inovio Pharmaceuticals.

Using Inovio Put Option to Manage Risk

Put options written on Inovio Pharmaceuticals grant holders of the option the right to sell a specified amount of Inovio Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Inovio Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Inovio Pharmaceuticals' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Inovio Pharmaceuticals will be realized, the loss incurred will be offset by the profits made with the option trade.

Inovio Pharmaceuticals' PUT expiring on 2022-12-09

   Profit   
Share
       Inovio Pharmaceuticals Price At Expiration  

Current Inovio Pharmaceuticals Insurance Chain

DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Put
2022-12-09 PUT at $2.0-0.7911.6098852022-12-090.14 - 0.230.18View
View All Inovio Pharmaceuticals Options

Inovio Pharmaceuticals Stock Volatility Analysis

Volatility refers to the frequency at which Inovio Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Inovio Pharmaceuticals' price changes. Investors will then calculate the volatility of Inovio Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Inovio Pharmaceuticals' volatility:

Historical Volatility

This type of stock volatility measures Inovio Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Inovio Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Inovio Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Inovio Pharmaceuticals' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Inovio Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
.

Inovio Pharmaceuticals Projected Return Density Against Market

Considering the 90-day investment horizon the stock has the beta coefficient of 2.1301 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Inovio Pharmaceuticals will likely underperform.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Inovio Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Inovio Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Inovio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Inovio Pharmaceuticals is significantly underperforming NYSE Composite.
   Predicted Return Density   
       Returns  
Inovio Pharmaceuticals' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how inovio stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Inovio Pharmaceuticals Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Inovio Pharmaceuticals Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Inovio Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Inovio Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Inovio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Considering the 90-day investment horizon the coefficient of variation of Inovio Pharmaceuticals is -1749.9. The daily returns are distributed with a variance of 26.56 and standard deviation of 5.15. The mean deviation of Inovio Pharmaceuticals is currently at 4.0. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 1.49
α
Alpha over NYSE Composite
-0.18
β
Beta against NYSE Composite2.13
σ
Overall volatility
5.15
Ir
Information ratio -0.02

Inovio Pharmaceuticals Stock Return Volatility

Inovio Pharmaceuticals historical daily return volatility represents how much of Inovio Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company has volatility of 5.154% on return distribution over 90 days investment horizon. By contrast, NYSE Composite accepts 1.4941% volatility on return distribution over the 90 days horizon.
 Performance (%) 
       Timeline  

About Inovio Pharmaceuticals Volatility

Volatility is a rate at which the price of Inovio Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Inovio Pharmaceuticals may increase or decrease. In other words, similar to Inovio's beta indicator, it measures the risk of Inovio Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Inovio Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for 2022
Market CapitalizationB864 M

Inovio Pharmaceuticals Investment Opportunity

Inovio Pharmaceuticals has a volatility of 5.15 and is 3.46 times more volatile than NYSE Composite. 44  of all equities and portfolios are less risky than Inovio Pharmaceuticals. Compared to the overall equity markets, volatility of historical daily returns of Inovio Pharmaceuticals is lower than 44 () of all global equities and portfolios over the last 90 days. Use Inovio Pharmaceuticals to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a very speculative upward sentiment. Check odds of Inovio Pharmaceuticals to be traded at $1.6435 in 90 days.

Poor diversification

The correlation between Inovio Pharmaceuticals and NYA is 0.62 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and NYA in the same portfolio, assuming nothing else is changed.

Inovio Pharmaceuticals Additional Risk Indicators

The analysis of Inovio Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Inovio Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Inovio Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Inovio Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Inovio Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Inovio Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Inovio Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Inovio Pharmaceuticals.
Please see Risk vs Return Analysis. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for analysis

When running Inovio Pharmaceuticals price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Is Inovio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
459.1 M
Quarterly Revenue Growth YOY
30.382
Return On Assets
(0.43) 
Return On Equity
(0.92) 
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Inovio Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.